151 related articles for article (PubMed ID: 35332788)
21. Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system.
Van Heukelom J; Morgan J; Massmann A; Jacobsen K; Petry NJ; Baye JF; Frear S; Schultz A
Front Pharmacol; 2023; 14():1274165. PubMed ID: 38035031
[No Abstract] [Full Text] [Related]
22. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM
Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy.
Roosan D; Hwang A; Roosan MR
Pharmacogenomics J; 2021 Feb; 21(1):1-7. PubMed ID: 32843688
[TBL] [Abstract][Full Text] [Related]
24. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
[TBL] [Abstract][Full Text] [Related]
25. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
[TBL] [Abstract][Full Text] [Related]
26. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
[TBL] [Abstract][Full Text] [Related]
27. Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting.
Tonti E; Lee YM; Gruenke N; Ferren J; Stutzman DL
J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):52-60. PubMed ID: 38377527
[No Abstract] [Full Text] [Related]
28. Knowledge and attitudes of incoming pharmacy students toward pharmacogenomics and survey reliability.
Wen YF; Jacobson PA; Oetting WS; Pereira C; Brown JT
Pharmacogenomics; 2022 Nov; 23(16):873-885. PubMed ID: 36314296
[TBL] [Abstract][Full Text] [Related]
29. Application of Pharmacogenomics Testing in a Community-based Facility.
Wang J; Paul S; Arbet RN; Lin AC
Hosp Pharm; 2023 Feb; 58(1):98-105. PubMed ID: 36644742
[TBL] [Abstract][Full Text] [Related]
30. Impact of medication synchronization programs on proportion of days covered (PDC) scores and Medicare Part D medication-related adherence metrics.
Bernard K; Cowles B; McCall K; Henningsen RM; O'Toole M; Tu C
J Am Pharm Assoc (2003); 2019; 59(3):343-348. PubMed ID: 30940515
[TBL] [Abstract][Full Text] [Related]
31. Patient perceptions of pharmacogenomic testing in the community pharmacy setting.
Bright D; Worley M; Porter BL
Res Social Adm Pharm; 2021 Apr; 17(4):744-749. PubMed ID: 32741696
[TBL] [Abstract][Full Text] [Related]
32. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
[No Abstract] [Full Text] [Related]
33. Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-
Kisor DF; Petry NJ; Bright DR
Pharmgenomics Pers Med; 2021; 14():569-577. PubMed ID: 34040417
[TBL] [Abstract][Full Text] [Related]
34. Fetal pharmacogenomics: A promising addition to complex neonatal care.
Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
[TBL] [Abstract][Full Text] [Related]
35. Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States.
Lemke LK; Alam B; Williams R; Starostik P; Cavallari LH; Cicali EJ; Wiisanen K
Front Pharmacol; 2023; 14():1179364. PubMed ID: 37645439
[No Abstract] [Full Text] [Related]
36. Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis.
Virelli CR; Mohiuddin AG; Kennedy JL
Transl Psychiatry; 2021 Oct; 11(1):509. PubMed ID: 34615849
[TBL] [Abstract][Full Text] [Related]
37. An objective evaluation of fundamental pharmacogenomics knowledge among pharmacists and pharmacy students.
Mehtar M; Hammoud SH; Amin MEK
Saudi Pharm J; 2022 Dec; 30(12):1765-1772. PubMed ID: 36601506
[TBL] [Abstract][Full Text] [Related]
38. Effect of pharmacogenomic testing on pharmacotherapy decision making in patients with symptoms of depression in an interprofessional primary care clinic.
Roscizewski L; Henneman A; Snyder T
J Am Pharm Assoc (2003); 2022; 62(2):569-574.e1. PubMed ID: 34801407
[TBL] [Abstract][Full Text] [Related]
39. Medication Optimization Using Pharmacogenomic Testing in a Complex Mental Health Population Prescribed Psychiatric Polypharmacy.
Wood AE; Agrawal D; Deem AP; Dupper Knoper TL; Merino RF; Molzof HE; Maus LE; Kim F; Lodin Z; Lim S
J Clin Pharmacol; 2022 Jul; 62(7):898-904. PubMed ID: 35075665
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
